Private Label Glycolic Acid Eye Cream Manufacturer Low MOQ

Most private label glycolic acid eye cream manufacturers offer MOQs between 250 and 2,000 units, depending on formula complexity, packaging customization, and the lab's production setup. At the lowest end, 250–500 units is achievable through smaller, agile contract manufacturers and co-packers who specialize in indie brands and direct-to-consumer founders. These labs typically have shorter production runs and smaller batch sizes, which means they can absorb the setup costs across fewer units without passing prohibitive per-unit charges to you. However, MOQ does not move on price alone. A lab with a 250-unit floor may still demand higher unit costs (often $8–15 per finished unit for a basic glycolic acid eye cream) because they're running a short batch, setting up equipment, and holding more overhead per unit. Labs offering 500-unit MOQs often sit in the sweet spot: low enough to be accessible to early-stage brands, but high enough that the manufacturer can optimize line efficiency and drop unit costs to $6–12 per unit depending on formula and packaging. Factors that raise MOQ include custom packaging (embossed jars, branded caps, or specialized containers), inclusion of exotic actives beyond glycolic acid (peptides, hyaluronic acid, retinol), stability testing demands, and regulatory dossier preparation. A standard glycolic acid eye cream with stock packaging—jar, label, and box—almost always stays in the 250–1,000 unit range. Conversely, if you accept a pre-formulated, shelf-tested glycolic acid eye cream base and apply your label to existing stock jars, some labs will go as low as 100 units. First-time manufacturers often underestimate the labor cost of a short run. Every batch, no matter the size, requires cleaning the equipment, calibrating scales, running stability tests, and completing regulatory paperwork. A 250-unit order spreads this fixed cost over fewer units, so your per-unit price rises. The mistake founders make is chasing the lowest MOQ without understanding that MOQ and unit cost are inversely related until you hit 1,000–2,000 units, where economies of scale flatten. When comparing manufacturers on AJ Cosmo Labs—the iOS app that connects you with vetted cosmetic chemists and contract manufacturers—filter by MOQ in the 250–1,000 range and ask each lab to quote both the MOQ price and the price at 1,000 units. This reveals the true cost structure and helps you forecast growth without overpaying for small batches. Many labs also offer tiered pricing: your first order at 250 units costs $X per unit, your second at 500 units costs $Y per unit (lower), and your third at 1,000 units locks in the best rate. This structure aligns their incentive to grow with you while protecting your cash flow as a startup.

The total timeline from order placement to finished product ready to ship is typically 8–16 weeks for a private label glycolic acid eye cream, broken into four distinct phases: formula customization (if any), manufacturing, stability testing, and packaging/fulfillment. For a low-MOQ run, expect the longer end of this range because smaller batches move more slowly through shared manufacturing lines. Formula customization is the first and most variable stage. If you're launching with a pre-formulated, already-tested glycolic acid eye cream base—one the lab has stability data for—you skip this phase entirely and save 2–4 weeks. If you want to adjust the glycolic acid concentration (typically 5–10% by weight in eye creams), add a secondary active like niacinamide or peptides, or reformulate for a specific texture (gel-cream, lightweight serum-cream), the lab's chemist needs 1–3 weeks to develop the formula and run preliminary bench tests. This phase is not mandatory for low-MOQ runs; many indie brands choose a stable, existing formula to hit the market faster. Manufacturing itself, once the formula is locked, usually takes 2–4 weeks. The lab schedules your batch on the production calendar, which depends on their current backlog. Labs with short lead times often have dedicated small-batch lines or reserve capacity for indie brands. Glycolic acid eye creams are water-in-oil or oil-in-water emulsions, and mixing time is brief (2–6 hours per batch), but QC testing for pH, viscosity, and glycolic acid concentration adds 1–2 days per batch. For a 500-unit order, the actual "batch time" is 1–2 weeks, but the lab may hold it in queue for 1–2 weeks before starting, so total manufacturing window is 2–4 weeks from lab's receipt of approval. Stability testing is where time extends unpredictably. Full stability testing—real-time storage at room temperature and accelerated storage at 40°C/75% relative humidity—takes 8–12 weeks. However, most labs do not require you to wait for full stability before shipping your first production run. Instead, they'll conduct accelerated stability in parallel and provide interim reports. If you're willing to accept a conditional release (the lab holds the right to recall product if stability fails, which is rare), you can ship products at week 6–8 of the timeline. For a low-MOQ run, discuss this upfront with the manufacturer; many will fast-track conditional release for indie brands to reduce time-to-market. Packaging and fulfillment add 1–3 weeks. Once the bulk glycolic acid eye cream is manufactured and passed initial QC, it's transferred to your jars, caps are sealed, labels are applied (manually for small runs, semi-automated for medium runs), and the finished goods are boxed and palletized. For 500 units, expect 1–2 weeks; for 1,000–2,000 units, 2–3 weeks. If your packaging supplies are already at the lab, this phase is faster. If they ship from a separate supplier, delays here can extend the total timeline by 1–2 weeks. On AJ Cosmo Labs, when you post your project brief or search for manufacturers, always ask for a detailed timeline that specifies each phase and confirms whether stability testing can be run in parallel (conditional release). The most common mistake is not accounting for lead time variability: a lab may promise 12 weeks, but if your formula requires a chemist revision or your packaging supplier delays shipment, you're looking at 14–16 weeks. Building in a 2–week buffer is prudent for launches where timing matters (seasonal, influencer partnerships, etc.). Labs that publish transparent phase timelines and offer weekly status updates are more likely to deliver predictably.

Per-unit cost for private label glycolic acid eye cream ranges from $6 to $18 per finished unit, depending on MOQ, glycolic acid concentration, secondary actives, packaging quality, and whether you're buying from a specialized micro-lab or a larger regional co-packer. For a 250–500 unit low-MOQ run, expect $12–18 per unit for a basic 5–7% glycolic acid formula in a standard 15–30 mL jar with printed label and box. For a 1,000–2,000 unit run, costs drop to $8–12 per unit. At 5,000+ units, you're typically in the $6–10 range with room to negotiate further. The cost breakdown reveals where the largest and smallest charges hide. Raw materials (glycolic acid, humectants like glycerin or hyaluronic acid, emollients, preservatives, stabilizers, pH buffers) account for $0.80–2.50 per unit depending on formula complexity and whether you include expensive actives like peptides or niacinamide. A glycolic acid eye cream with just glycolic acid, glycerin, dimethicone, and preservatives sits at the low end ($0.80–1.20 per unit). If you add a peptide complex or a secondary exfoliant, raw materials climb to $1.50–2.50 per unit. Packaging is often the largest cost after labor. A 30 mL airless pump jar with a custom label, inner carton, and outer shipping box costs $1.50–4.00 per unit for a low-MOQ run. Standard plastic jars with screw caps and labels run $1.00–2.50 per unit. If you choose luxury packaging—glass jars, embossed closures, or specialty foil-lined boxes—expect $3.00–6.00 per unit just for the container. Packaging is where the biggest discounts appear as volume increases: a jar that costs $3.00 at 500 units may drop to $1.50 at 5,000 units because the supplier achieves better injection-molding economies and reduces design setup fees. Laboratory fees and overhead are where smaller MOQs sting. Contract manufacturers charge setup fees ($500–2,000) that are amortized across your total order; a 250-unit batch spreads this cost to $2–8 per unit, while a 2,000-unit batch spreads it to $0.25–1.00 per unit. QC, regulatory documentation, and conditional stability testing add $0.50–2.00 per unit depending on how rigorous the lab is. A manufacturer that includes regulatory support (ingredient verification, claims substantiation, SDS preparation) will charge more upfront but saves you the cost of hiring a regulatory consultant separately. Secondary actives and formula complexity directly move the cost. A straightforward glycolic acid and glycerin eye cream with a simple preservative system costs less than a formula with glycolic acid, peptides, niacinamide, hyaluronic acid, squalane, and a multi-phase delivery system. Each extra active adds raw material cost, requires additional stability testing, and may increase manufacturing time (longer mixing, more QC checkpoints). This is why many indie brands start with a simpler formula at low MOQ—to validate market fit at lower cost-per-unit—and then reformulate upward with additional actives once they've committed to larger volumes. Regional manufacturing also influences cost. Labs in the United States and Western Europe typically charge $1–3 more per unit than labs in Asia or Eastern Europe because of labor and facility costs. However, this premium often includes better regulatory support for US/EU markets, faster turnaround, and closer oversight. On AJ Cosmo Labs, when you search for glycolic acid eye cream manufacturers, you can filter by region and see how per-unit quotes vary. The largest mistake founders make is optimizing for the lowest per-unit cost at the expense of formula quality or turnaround time. A $6 per unit quoted by an untested lab may deliver a separated emulsion or stability failure, forcing you to re-order and wasting your initial investment. Always request samples, stability reports, and references before committing to a manufacturer, even if their quote is the cheapest.

The core structure of a glycolic acid eye cream contains four essential ingredient categories: the alpha-hydroxy acid (glycolic acid itself), a buffering system (typically sodium hydroxide or triethanolamine), hydrating and soothing actives, and a stable emulsion base. Glycolic acid is the star; it typically sits at 5–10% by weight in eye creams. The FDA classifies glycolic acid as a cosmetic ingredient (not a drug) when used for exfoliation and skin conditioning, which means it does not require pre-market approval. However, concentrations above 10% in rinse-off products, or higher levels in leave-on products, can drift into drug territory if claims like "reduces wrinkles" or "repairs skin damage" are made, which triggers FDA scrutiny. The pH of the formulation is critical for safety and efficacy. Glycolic acid is naturally acidic (pKa ~3.9), and an unbuffered 7% glycolic acid solution would be pH ~2, which is too harsh for delicate eye skin and risks irritation or even chemical burn. Manufacturers buffer glycolic acid to pH 3.0–4.0 using sodium hydroxide, potassium hydroxide, or triethanolamine. This buffer protects the skin while allowing glycolic acid to penetrate and exfoliate. The pH is validated during QC and stability testing; a well-formulated eye cream maintains pH within ±0.3 units over 12 months of storage. Secondary actives and humectants are layered to reduce irritation and provide hydration. Glycerin, hyaluronic acid (sodium hyaluronate at 0.5–2% by weight), propylene glycol, and panthenol are standard inclusions. These ingredients hydrate the epidermis and attract water, counteracting the slightly drying effect of glycolic acid. Many indie brands also add soothing actives like allantoin, bisabolol, or centella asiatica extract (0.5–2%) to calm inflammation. Niacinamide (2–5%) is a popular co-active because it strengthens the skin barrier, reduces redness, and synergizes well with glycolic acid. Some formulators include peptides (Matrixyl, Argireline) or resveratrol, which add cost ($1–2 per unit in raw materials) but appeal to premium positioning. The emulsion base—typically an oil-in-water (O/W) or water-in-oil (W/O) cream—provides texture, spreadability, and occlusion. Glycolic acid eye creams are often formulated as lightweight O/W emulsions to avoid the heavy, occlusive feel of a traditional night cream. Key emollients include dimethicone (2–5%), squalane, cetyl alcohol, and plant oils (jojoba, squalane). Emulsifiers like ceteth-20, polysorbate 80, or cetyl alcohol stabilize the emulsion. Preservatives are essential: phenoxyethanol, sodium benzoate/potassium sorbate combinations, or newer options like Leuconostoc ferment filtrate are common in glycolic acid eye creams to prevent microbial growth, especially given the water content from hydrating actives. Regulatory restrictions vary by geography. In the United States, the FDA allows glycolic acid in cosmetics without pre-market approval, and there is no official concentration cap, though industry best practice and dermatology standards suggest 5–10% for leave-on eye products. The EU restricts glycolic acid in rinse-off products to a maximum of 30% at pH >3.5 (per the Cosmetics Regulation Annex III), but leave-on products like eye creams have no explicit percentage cap—only a requirement that the finished product must be safe and stable. Canada (Health Canada) treats glycolic acid as a cosmetic ingredient with no specific restrictions on concentration, but products must meet the Canadian Natural and Non-prescription Health Products Directorate (NNHPD) labeling and safety standards. Claims restrictions are the biggest regulatory pitfall. You cannot claim that a glycolic acid eye cream "reduces wrinkles," "reverses photoaging," or "treats acne" without converting the product into a drug in most jurisdictions. Claims must be limited to "exfoliates," "conditions skin," "smooths appearance," "moisturizes," or "refines texture." Any claim that implies a therapeutic benefit (disease treatment or prevention) triggers drug status and requires clinical trials and FDA approval. On AJ Cosmo Labs, when you brief a chemist or manufacturer, specify your intended claims upfront; a good lab will steer your formula and claims strategy to stay in the cosmetic lane and avoid regulatory delays. The most common mistake is assuming that glycolic acid eye cream is inherently gentler or safer than higher-concentration glycolic acid products. Eye skin is thinner and more sensitive than facial skin; a 10% glycolic acid eye cream is stronger than a 5% formula, and even well-formulated high concentrations can trigger irritation, erythema, or sensitization in some users. Manufacturers should recommend a patch test on packaging and suggest use 2–3 times per week initially. Stability testing must confirm that pH, glycolic acid concentration, and emulsion integrity remain within specification over the intended shelf life (typically 24–36 months). Request the final stability reports and Certificate of Analysis from any manufacturer before committing to production.

The most efficient way to find and vet a private label glycolic acid eye cream manufacturer is to use a dedicated B2B marketplace like AJ Cosmo Labs, which pre-screens labs and co-packers, allows you to filter by MOQ, geographic region, and certifications, and hosts a free project-posting feature where multiple vetted manufacturers can submit competitive bids. After identifying candidates, run a three-stage vetting process: formula and capability review, sample evaluation, and regulatory/reference checks. On AJ Cosmo Labs (available on the App Store), post a brief describing your vision: desired glycolic acid concentration (e.g., 7%), key actives (e.g., hyaluronic acid + niacinamide), texture preference (e.g., lightweight gel-cream), MOQ target (e.g., 300–500 units), budget per unit, and timeline. The app will surface manufacturers that have explicitly stated they accept low-MOQ orders in your region. This eliminates labs that require 5,000+ unit minimums and saves you weeks of outbound research. Each manufacturer profile on the app includes certifications (GMP, FDA registration, ISO standards) and previous work (brands they've manufactured for, if disclosed). Filter for labs with 4.5+ star ratings and explicit low-MOQ listings. Once you've narrowed to 3–5 candidates, request their complete manufacturing capabilities packet, which should include: their MOQ policy, unit costs at your target volume and at higher volumes (to understand scaling), estimated timeline broken into phases (formula customization, manufacturing, stability testing, packaging), regulatory support offered (do they handle ingredient verification, SDS, regulatory documentation?), and current production capacity (are they backlogged?). Red flags include vague timelines ("around 12 weeks"), no published MOQ, unwillingness to provide price breaks, and lack of clarity on stability testing protocols. Request a sample—this is non-negotiable. Ask the manufacturer for a pre-formulated glycolic acid eye cream sample (ideally in a small 5–10 mL jar so cost is minimal) that matches or is close to your target specification. Evaluate the sample across several dimensions. First, physical properties: does the emulsion appear homogeneous and well-mixed, or are there oil droplets, separation, or grittiness (signs of instability or contamination)? Is the texture smooth, non-greasy, and easy to spread? Does it absorb without leaving a tacky residue? Second, sensory safety: apply a small amount to the inner forearm (not the eye) and wait 10 minutes. Any stinging, redness, or irritation in this patch test suggests the pH is off or the formula is too harsh. Third, stability indicators: if the lab provides a sample that's 6+ months old, inspect the lid seal and container for signs of oxidation or discoloration. Ask the lab how long that sample has been stored and under what conditions; a well-preserved sample suggests good product handling. Request the lab's stability data and Certificate of Analysis for the sample formula. The CoA should confirm: glycolic acid concentration (within ±5% of stated level), pH (typically 3.0–4.0 for a glycolic acid eye cream), microbial testing results (should show <100 CFU/mL for bacteria, <10 CFU/mL for fungi), and viscosity (reported in cP or centipoises, should match a reference range). Accelerated stability data showing that the formula passed testing at 40°C/75% RH for at least 4–8 weeks is acceptable for a launch (full 12-week data can come post-launch). Any CoA with missing microbial or pH data is a warning sign; the lab is cutting corners on QC. Check regulatory and reference credentials. Ask for at least two references from other indie brands or resellers that have used this manufacturer for similar products (eye creams, serums, or other low-MOQ cosmetics). Contact them directly and ask: Did the lab deliver on timeline? Were there any quality issues or rework required? Would they order again? Also verify that the manufacturer is FDA-registered (if US-based) and holds any relevant certifications: ISO 9001 (quality management), GMP (good manufacturing practice), or cruelty-free/vegan certifications if those matter to your brand. A GMP certification is especially important for low-MOQ runs because it signals that the lab maintains rigorous QC standards even on small batches. During this vetting process, ask each manufacturer: "What happens if the finished product fails stability testing or CoA?" A good lab will commit to remediation—reformulating, re-manufacturing, or issuing a credit—at no additional cost if the failure is the lab's fault (e.g., contamination, pH drift). Clarify liability and quality guarantees in writing before signing a contract. The biggest mistake founders make is rushing to the cheapest manufacturer without vetting samples; a low-MOQ formula that arrives contaminated, separated, or with off-pH is worthless and forces a costly reorder. Spend 2–3 weeks upfront on vetting; it prevents months of delays and wasted capital.

The five most frequent issues that indie brands encounter when launching a private label glycolic acid eye cream are: pH instability or creep (pH rises over time, reducing glycolic acid efficacy and risking irritation), emulsion separation or breaking (oil and water phases split, creating an unusable product), glycolic acid degradation or oxidation (concentration drops during storage, weakening the product), inadequate preservation leading to microbial contamination, and over-concentration causing irritation or sensitization complaints. Each is preventable with proper formula design, stability testing, and manufacturer oversight. pH instability is the most insidious because it often occurs gradually over weeks or months. Glycolic acid is buffered at pH 3.0–4.0 using sodium hydroxide or triethanolamine, but in the presence of air (oxygen), light, and heat, the buffer can drift upward as glycolic acid oxidizes or as the buffer agent reacts with trace metals or impurities in the formula. A product that ships at pH 3.2 may arrive at a distributor's warehouse at pH 3.5 and, after 6 months on a shelf under fluorescent lights, drift to pH 4.2. At pH 4.2 or higher, glycolic acid's penetration and exfoliating efficacy diminish sharply, and user reviews will reflect "didn't notice a difference." To avoid this, ensure the manufacturer uses a stabilized buffer system (often including chelating agents like EDTA to bind trace metals) and packages the cream in opaque, air-tight containers (glass or opaque plastic jars with tight seals, not clear plastic or jars with gaps). Request that the lab run pH testing at baseline, 4 weeks, 8 weeks, and 12 weeks of accelerated stability at 40°C/75% RH; pH should not drift more than ±0.3 units. If it does, ask the manufacturer to reformulate the buffer or switch to a different chelating agent. Emulsion separation is another top failure mode, particularly in glycolic acid eye creams that combine water-loving hydrating actives (glycerin, hyaluronic acid) with oil-based emollients (dimethicone, squalane). If the emulsifier concentration is too low, or if the ratio of oil to water is out of balance, the emulsion can break during storage or shipping (especially if containers experience temperature swings). Signs include visible oil or water droplets in the jar, a grainy texture, or separation of a liquid layer on top. This is both a cosmetic and a functional failure—an unstable emulsion degrades active ingredients, loses the intended texture, and communicates poor quality. Manufacturers prevent this by selecting robust emulsifiers (ceteth-20, polysorbate 80, or lecithin-based systems) at concentrations of 3–6% and validating emulsion stability under stress conditions (heating-cooling cycles, freeze-thaw cycles, vigorous shaking) in the lab before production. Always ask for emulsion stability testing (not just microbial and pH); a competent manufacturer will provide data showing the emulsion remained homogeneous through 3–5 heating-cooling cycles from 25°C to 40°C and back. Glycolic acid degradation occurs when the active is exposed to alkaline conditions, high heat, or high light. Glycolic acid is most stable at pH 3.0–4.0; if pH rises above 4.5, glycolic acid begins to degrade (hydrolyze) and loses potency. Conversely, if the formula is stored above 30°C (especially above 40°C) or under direct sunlight, oxidation can degrade glycolic acid over weeks. To mitigate, work with a manufacturer that uses UV-stabilized or opaque packaging, tests storage at controlled temperatures, and includes an antioxidant (vitamin E, ferulic acid, or sodium metabisulfite) to protect glycolic acid from oxidation. Request the manufacturer confirm glycolic acid concentration at baseline and after 12 weeks of accelerated storage; concentration should remain within 95–105% of the stated level. A drop below 95% signals either degradation or measurement error, both of which warrant investigation. Microbial contamination is a regulatory and safety disaster. Glycolic acid eye creams contain water and hydrating actives, which are susceptible to mold and bacterial growth if the preservative system is inadequate. A product that passes microbial testing at release but then develops mold six months later on a retailer's shelf is a sign that the preservative level was underestimated or that the water activity (aw) was not controlled. Manufacturers must select a preservative system appropriate for the formula's water content and intended shelf life. A typical glycolic acid eye cream with 30–50% water requires a multi-component preservative: phenoxyethanol (0.5–1%) plus sodium benzoate and potassium sorbate (0.5–1% total) or a newer option like Leuconostoc ferment filtrate (0.5–1%). The lab should conduct a challenge test, in which the formula is deliberately inoculated with microbes and the preservative's ability to control microbial growth is measured over time. This is a formal requirement under ISO 11930 and the Cosmetics Regulation. Do not accept a CoA that lists "passes USP <61> microbial limits" (standard microbial plate count) without evidence of a formal challenge test; standard testing only confirms the absence of contamination at release, not the preservative's long-term efficacy. Over-concentration or irritation complaints arise when the glycolic acid level is too high, the pH is too low, or secondary actives are included at concentrations that heighten irritation. A 12% glycolic acid eye cream, even at pH 3.5, can cause persistent redness, stinging, or sensitization in users with sensitive skin or those who use it more than 2–3 times per week. Many indie brands are tempted to increase glycolic acid concentration to compete on "strength" or efficacy, but this is a liability risk and leads to customer complaints and returns. Stick to 5–10% glycolic acid for an eye cream, and always include clear usage instructions on the label: "Use 2–3 times per week. Do not use daily. Discontinue if irritation occurs." If you include secondary actives like niacinamide, resveratrol, or peptides, confirm with the manufacturer that the combined irritancy has been assessed. Some combinations (e.g., glycolic acid + high-dose retinol + strong essential oils) are too irritating for eye skin and will generate complaints. The biggest mistake founders make is launching without conducting a formal consumer patch test or sensitivity study. Before sending products to retailers or influencers, recruit 10–20 volunteers from your target demographic, provide them with the product and clear instructions, and ask them to report any irritation, stinging, or unusual reactions over 4 weeks of use at the recommended frequency. A simple survey asking "Did you experience any discomfort or redness?" will surface irritation issues before they become public reviews. Work with the manufacturer to validate that your formula meets the Sensitive Skin/Eye Irritation criteria (typically <1% irritation rate in a 20–50 subject patch test). This step is especially critical for eye products, where safety concerns drive regulatory scrutiny and customer trust.

Yes, you can customize a pre-formulated glycolic acid eye cream by adding or substituting secondary actives, but the cost, timeline, and complexity depend on what you want to change, how it affects formula stability, and whether the lab has already validated the ingredient combination. Adding a single ingredient to an existing, stable formula (like including an extra 2% niacinamide to a baseline glycolic acid cream) is relatively straightforward and costs $1,500–3,000 for reformulation and abbreviated stability testing. Replacing multiple ingredients or rebuilding the formula from scratch is more expensive and time-consuming. First, understand the difference between "ingredient addition" and "reformulation." An ingredient addition means you keep the core structure (glycolic acid, buffer, emulsion base, preservative) and layer in an extra active or increase the concentration of an existing one. For example, the baseline formula might be: 7% glycolic acid, 3% glycerin, 2% hyaluronic acid, 2% dimethicone, and standard preservative. You ask the lab to boost hyaluronic acid to 3.5% and add 2% peptides (Matrixyl 3000 or similar). The lab adjusts the formula, which involves recalculating the water/oil ratio, retesting emulsion stability, running accelerated stability for 4–8 weeks, and updating the CoA. This costs roughly $2,000–3,500 and takes 6–10 weeks. A reformulation that rebuilds the entire formula (changing the emulsion type from O/W to W/O, replacing the emollient base, or using a different glycolic acid buffer) is a full custom formulation and costs $4,000–10,000 with a 10–16 week timeline. Before you invest in customization, ask the manufacturer: "Do you have stability data for this specific ingredient combination?" If the lab has already formulated a glycolic acid eye cream with peptides and has stability data on file, adding peptides to your order is straightforward—the lab simply manufactures the pre-validated formula at your MOQ and charges minimal customization fees ($500–1,000 to adjust ingredient sourcing and documentation). If the combination is novel, expect the full cost and timeline. This is why shopping on AJ Cosmo Labs is valuable: many labs list pre-formulated options with different active combinations (glycolic acid + niacinamide, glycolic acid + peptides, glycolic acid + squalane), each with stability data. Selecting a pre-formulated option saves months and thousands in development costs. Common actives that are easy to add or substitute in a glycolic acid eye cream include: additional hydrators (boosting hyaluronic acid from 1% to 3%), soothing agents (adding allantoin, bisabolol, or centella asiatica at 0.5–2%), vitamins (vitamin E, ferulic acid, or niacinamide at 2–5%), peptides (Matrixyl, Argireline, Syn-Ake at 2–5%), and plant oils (adding 1–3% rosehip or jojoba oil). These ingredients are well-known, stable, and compatible with glycolic acid formulations. Their addition requires recalculating the water/oil balance and running accelerated stability, but the risk of the formula breaking or becoming unstable is low. Cost typically ranges from $1,500–3,000 for lab time, materials, and abbreviated stability. Difficult or expensive customizations include: adding actives known to be incompatible with glycolic acid (retinol or retinoids, which can degrade glycolic acid or increase irritation), including thermolabile ingredients (collagen, live probiotics, or enzyme complexes that break down in water), or trying to include fragrance or essential oils at high concentrations (which can irritate eye skin and are not recommended for eye products). If you want to include retinol, the lab must formulate it in a separate encapsulation system (a retinol-containing oil droplet or liposome) to isolate it from the aqueous glycolic acid phase. This requires specialized knowledge, additional stability testing, and costs $3,000–8,000 with 12–16 week lead time. For an indie brand with low MOQ, encapsulation is often not worth the investment; most labs will advise against it or recommend launching a glycolic acid eye cream first, then a retinol eye cream as a separate SKU. Customization also affects per-unit cost. If you're paying $10 per unit for a baseline glycolic acid eye cream and you add 2% peptides (which cost $3–8 per kg, a small upcharge), your cost may rise by $0.50–1.50 per unit depending on the peptide type. Niacinamide (cheap, ~$2–5 per kg) might add only $0.20 per unit, while a bioactive peptide or growth factor complex could add $2–3 per unit. Ask the lab for a detailed BOM (bill of materials) showing the raw material cost per unit for your customized formula; this helps you understand the true cost structure and whether the added active justifies a higher retail price. A critical mistake is requesting customization without clear justification or market research. If you want to add peptides because you think it sounds premium, but your target customer doesn't value peptides and won't pay a higher price, you've added cost and complexity for no return. Before requesting customization, validate with your audience: survey potential customers, check competitor positioning, and confirm that the added ingredient supports your brand story or USP. Another mistake is assuming that adding more actives (peptides, hyaluronic acid, squalane, vitamins) makes the formula "better." Eye skin is delicate; overloading a formula with multiple actives can increase irritation risk, complicate stability, and raise the cost per unit without improving efficacy. A clean, simple glycolic acid eye cream (glycolic acid, glycerin, hyaluronic acid, dimethicone, niacinamide) is often more effective and easier to manufacture reliably than a formula with six actives. Discuss with the lab whether your proposed customizations genuinely improve the product or just add complexity and cost.